Menu
GeneBe

13-50929494-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3

The NM_024570.4(RNASEH2B):c.156G>T(p.Leu52Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. L52L) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)

Consequence

RNASEH2B
NM_024570.4 missense

Scores

6
11
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.41
Variant links:
Genes affected
RNASEH2B (HGNC:25671): (ribonuclease H2 subunit B) RNase H2 is composed of a single catalytic subunit (A) and two non-catalytic subunits (B and C) and specifically degrades the RNA of RNA:DNA hybrids. The protein encoded by this gene is the non-catalytic B subunit of RNase H2, which is thought to play a role in DNA replication. Multiple transcript variants encoding different isoforms have been found for this gene. Defects in this gene are a cause of Aicardi-Goutieres syndrome type 2 (AGS2). [provided by RefSeq, Nov 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.812

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RNASEH2BNM_024570.4 linkuse as main transcriptc.156G>T p.Leu52Phe missense_variant 3/11 ENST00000336617.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RNASEH2BENST00000336617.8 linkuse as main transcriptc.156G>T p.Leu52Phe missense_variant 3/111 NM_024570.4 P3Q5TBB1-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 30, 2021The c.156G>T (p.L52F) alteration is located in exon 3 (coding exon 3) of the RNASEH2B gene. This alteration results from a G to T substitution at nucleotide position 156, causing the leucine (L) at amino acid position 52 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Aicardi-Goutieres syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeMar 26, 2022In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with RNASEH2B-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 52 of the RNASEH2B protein (p.Leu52Phe). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Pathogenic
0.33
D
BayesDel_noAF
Pathogenic
0.24
Cadd
Benign
23
Dann
Uncertain
1.0
DEOGEN2
Uncertain
0.66
D;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;T;.
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.92
D;D;D;D;D;D;D;D;D;D;D;D;D;D;.;.;D;D
M_CAP
Pathogenic
0.40
D
MetaRNN
Pathogenic
0.81
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
0.98
D
MutationAssessor
Uncertain
2.7
M;M;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-3.2
D;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Pathogenic
0.80
Sift
Uncertain
0.010
D;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Uncertain
0.010
D;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Polyphen
1.0
D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.81
MutPred
0.56
Gain of catalytic residue at I50 (P = 0.001);Gain of catalytic residue at I50 (P = 0.001);Gain of catalytic residue at I50 (P = 0.001);Gain of catalytic residue at I50 (P = 0.001);.;Gain of catalytic residue at I50 (P = 0.001);.;Gain of catalytic residue at I50 (P = 0.001);Gain of catalytic residue at I50 (P = 0.001);Gain of catalytic residue at I50 (P = 0.001);Gain of catalytic residue at I50 (P = 0.001);Gain of catalytic residue at I50 (P = 0.001);.;.;.;.;.;.;
MVP
0.96
MPC
0.34
ClinPred
0.98
D
GERP RS
4.2
Varity_R
0.51
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35416748; hg19: chr13-51503630; API